Erasmus School of Health Policy & Management
Assistant professor | Health Technology Assessment (HTA)
- thielen@eshpm.eur.nl
More information
Work
- Michiel Zietse, Ruben Malmberg, Roelof W.F. van Leeuwen, Frederick W. Thielen & Carin A. Uyl – de Groot (2024) - The administration of immune checkpoint inhibitors via an elastomeric pump versus conventional intravenous infusion: an economic perspective - Bmc Health Services Research, 24 (1) - doi: 10.1186/s12913-024-11719-0 - [link]
- R. J.S.D. Heine, F. W. Thielen, R. H.J. Mathijssen, R. W.F. van Leeuwen, M. G. Franken & C. A. Uyl-de Groot (2024) - Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab - PLoS ONE, 19 (2 February) - doi: 10.1371/journal.pone.0293264 - [link]
- Leona Hakkaart - van Roijen, Stijn Peeters, Tim Kanters, Pieter van Baal, Werner Brouwer, Ruben Drost, Silvia M.A.A. Evers, Job van Exel, Vivian Reckers-Droog, Nasr-Eddine Tannaoui, Frederick Thielen & Ben Wijnen (2024) - <b>Kostenhandleiding </b>voor economische evaluaties in de gezondheidszorg:: Methodologie en Referentieprijzen - [link]
- Brenda Leeneman, Hedwig M. Blommestein, Annemieke van Dongen-Leunis, Mattia Algeri, Willem E. Fibbe, Liesbeth Oosten, Carin A. Uyl-de Groot & Frederick W. Thielen (2023) - Health-related quality of life in patients with steroid-refractory acute graft-versus-host disease - European Journal of Haematology, 111 (2), 240-246 - doi: 10.1111/ejh.13987 - [link]
- Lj Bakker, Fw Thielen, Wk Redekop, CA Uyl de Groot & Hm Blommestein (2023) - Extrapolating empirical long-term survival data: the impact of updated follow-up data and parametric extrapolation methods on survival estimates in multiple myeloma - BMC Medical Research Methodology, 23 (1) - doi: 10.1186/s12874-023-01952-2 - [link]
- Ngoc Do & Frederick W. Thielen (2023) - Cost-Effectiveness of Venetoclax Plus Obinutuzumab Versus Chlorambucil Plus Obinutuzumab for the First-Line Treatment of Adult Patients With Chronic Lymphocytic Leukemia: An Extended Societal View - Value in Health, 26 (4), 477-486 - doi: 10.1016/j.jval.2022.11.002 - [link]
- Frederick W. Thielen, Renaud J.S.D. Heine, Sibren van den Berg, Renske M.T.ten Ham & Carin A.Uyl de Groot (2022) - Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma - Cytotherapy, 24 (12), 1245-1258 - doi: 10.1016/j.jcyt.2022.09.002 - [link]
- Frederick W. Thielen, Renaud J.S.D. Heine, Sibren Van Den Berg, Renske M.T. Ten Ham & Carin A. Uyl-De Groot (2022) - Kostprijs-plusmodel geeft inzicht in reële prijzen gentherapieën - Pharmaceutisch Weekblad, 157 (47), 18-20 - [link]
- Frederick W. Thielen, Marie José Kersten, Pim Kuizenga, Mels Hoogendoorn, Eduardus F.M. Posthuma, Wendy B.C. Stevens, Carin A Uyl-de Groot & Hedwig M. Blommestein (2021) - Cost-effectiveness of lenalidomide plus rituximab versus rituximab monotherapy in patients with previously treated follicular lymphoma: a societal view - Expert Review of Anticancer Therapy, 21 (12), 1411-1422 - doi: 10.1080/14737140.2021.1971520 - [link]
- Kai Ruggeri, Julia P. Stuhlreyer, Johanna Emilia Immonen, Silvana Mareva, Maja Friedemann, Alessandro F. Paul, Matthew Lee, Rachel C. Shelton, Annalisa Robbiani, Frederick W. Thielen, Amiran Gelashvili, Filippo Cavassini & Faisal Naru (2021) - Policy evaluation and behavioral economics - doi: 10.4324/9781003181873-11 - [link]
- Renaud Heine, Frederick W. Thielen, Marc Koopmanschap, Marie José Kersten, Hermann Einsele, Ulrich Jaeger, Pieter Sonneveld, Jorge Sierra, Carin Smand & Carin A. Uyl-De Groot (2021) - Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future - HemaSphere, 5 (2) - doi: 10.1097/HS9.0000000000000524 - [link]
- Frederick Thielen (2020) - Current Challenges in Health Technology Assessment: Assessing costs and cost-effectiveness of novel treatments in haemato-oncology - [link]
- J. Brouwer, V. J. Nijenhuis, R. Delewi, R. S. Hermanides, W. Holvoet, C. L.F. Dubois, P. Frambach, B. de Bruyne, G. K. van Houwelingen, J. A.S. van der Heyden, P. Toušek, F. van der Kley, I. Buysschaert, C. E. Schotborgh, B. Ferdinande, P. van der Harst, J. Roosen, J. Peper, F. W.F. Thielen, L. Veenstra, D. R.P.P. Chan Pin Yin, M. J. Swaans, B. J.W.M. Rensing, A. W.J. van't Hof, L. Timmers, J. C. Kelder, P. R. Stella, J. Baan & J. M. ten Berg (2020) - Aspirin with or without clopidogrel after transcatheter aortic-valve implantation - New England Journal of Medicine, 383 (15), 1447-1457 - doi: 10.1056/NEJMoa2017815 - [link]
- VJ Nijenhuis, J Brouwer, R Delewi, RS Hermanides, W Holvoet, CLF Dubois, P Frambach, B De Bruyne, GK van Houwelingen, JAS Van Der Heyden, P Toušek, F van der Kley, I Buysschaert, CE Schotborgh, B Ferdinande, P van der Harst, J Roosen, J Peper, Frederick Thielen, L Veenstra, DRPP Chan Pin Yin, MJ Swaans, BJWM Rensing, A van 't Hof, L Timmers, JC Kelder, P Stella, J Baan & J ten Berg (2020) - Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation - New England Journal of Medicine, 382 (18), 1696-1707 - doi: 10.1056/NEJMoa1915152 - [link]
- Frederick Thielen, A van Dongen-Leunis, AMM Arons, JR Ladestein & PR Hoogerbrugge (2020) - Cost?effectiveness of Anti?CD19 chimeric antigen receptor T?Cell therapy in pediatric relapsed/refractory B?cell acute lymphoblastic leukemia. A societal view - European Journal of Haematology, 105 (2) - doi: 10.1111/ejh.13427 - [link]
- Frederick Thielen, Maite Houwing, Marjon Cnossen, IA Hadithy-Irgiztseva, Jan Hazelzet, Carin Uyl - de Groot, Anne de Pagter & Hedwig Blommestein (2020) - Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country - Pediatric Blood & Cancer, 67 (9) - doi: 10.1002/pbc.28588 - [link]
- BFM Wijnen, Frederick Thielen, S Konings, T Feenstra, M van der Gaag, W Veling, L De Haan, H Ising, M Hiligsmann, SMAA Evers, F Smit & J Lokkerbol (2019) - Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis - Expert review of pharmacoeconomics & outcomes research - doi: 10.1080/14737167.2019.1632194 - [link]
- Frederick Thielen, NC Büyükkaramikli, R Riemsma, D Fayter, N Armstrong, C-Y Wei, V Huertas Carrera, K Misso, G Worthy, J Kleijnen & Isaac Corro Ramos (2018) - Obinutuzumab in Combination with Chemotherapy for the First-Line Treatment of Patients with Advanced Follicular Lymphoma - Pharmacoeconomics (Print) - doi: 10.1007/s40273-018-0740-4 - [link]
- Frederick Thielen, Hedwig Blommestein, LEM Oosten, FG Calkoen, AC Lankester, JJ Zwaginga, K Le Blanc, A Redondo, F Sánchez?Guijo, M Algeri, F (Franco) Locatelli, WE Fibbe & Carin Uyl - de Groot (2018) - Second?line treatment for acute graft?versus?host disease with mesenchymal stromal cells: A decision model. - European Journal of Haematology, 101 (5), 676-683 - doi: 10.1111/ejh.13158 - [link]
- Frederick Thielen (2018) - Best Student Poster Presentation
- WF (Frederick) Thielen (2013) - ESST European Award for Aspiring Undergraduates
Dark Peak Analytics
- Start date approval
- januari 2022
- End date approval
- januari 2025
- Place
- SHEFFIELD
TriData
- Start date approval
- januari 2022
- End date approval
- januari 2025
- Place
- UTRECHT
- Description
- Teacher Statistical Programming & Data Science
Semester at Partner University
- Year
- 2024
- Course Code
- EU-HEM SEMESTER
Advanced Health Economic Modelling EuHEM
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4587M
Health Technology Assessment (Eu-HEM)
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4585M
Pharmaceutical Pricing and Market Access
- Year Level
- master, master, master, master
- Year
- 2024
- Course Code
- GW4575M
Master Thesis HEPL
- Level
- master
- Year Level
- master
- Year
- 2024
- Course Code
- GW4555M
Advanced Health Economic Modelling
- Year Level
- master, master, master
- Year
- 2024
- Course Code
- GW4563M
Master Thesis HE
- Year Level
- master, master
- Year
- 2024
- Course Code
- GW4592M
EU-HEM Summerschool 2024
- Year
- 2024
- Course Code
- GWSUM24
Master HEPL-HE 2024-2025
- Year
- 2024
- Course Code
- GWMTTHEPL
